(Q46613252)

23 December 2017

title

Experience with Alemtuzumab (Campath-1H) as induction agent in renal transplantation followed by steroid-free immunosuppression (English)

1 reference

23 December 2017

1 reference

Y Baez

1

1 reference

23 December 2017

F Giron

2

1 reference

23 December 2017

A Niño-Murcia

3

1 reference

23 December 2017

J Rodríguez

4

1 reference

23 December 2017

S Salcedo

5

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

23 December 2017

Transplantation Proceedings

published in

1 reference

23 December 2017

volume

40

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

697-699

1 reference

23 December 2017

Campath-1H in renal transplantation: The University of Wisconsin experience.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

The use of Campath-1H as induction therapy in renal transplantation: preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

Rapid discontinuation of prednisone in higher-risk kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

Reduction of CMV disease with steroid-free immunosuppresssion in simultaneous pancreas-kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

Renal transplantation in children managed with lymphocyte depleting agents and low-dose maintenance tacrolimus monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2008.02.026

10.1016/J.TRANSPROCEED.2008.02.026

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017